Podcast Summary: The Clay Travis and Buck Sexton Show

Episode: Wellness Unmasked: “White Plague” Explained — Why Tuberculosis Cases Are Rising Again
Date: March 31, 2026
Host: Dr. Nicole Saphier (featured segment: Wellness on Mass)
Platform: iHeartPodcasts

Episode Overview

This episode of the Wellness on Mass segment, hosted by Dr. Nicole Saphier, dives into the recent resurgence of tuberculosis (TB) in the United States, a disease historically known as the "white plague." Dr. Saphier unpacks the reasons behind rising TB cases, addresses public health challenges, and discusses the historical context, modern factors driving new cases, and actionable public health solutions—all with a focus on clarity and historical perspective.

Key Discussion Points & Insights

1. Origins and Meaning of “White Plague”

• Historical Framing:
  • The term "white plague" refers to tuberculosis, a name derived from its historical impact and the symptoms it produced: pale, gaunt patients slowly wasting away over months or years.
  • Dr. Saphier humorously admits, "White plague? What the heck is the white plague? Am I really that out of touch with reality that there's a plague going around and I don't even know about it?" (04:10)
• Historical Toll:
  • In the 18th and 19th centuries, TB caused up to 25% of all deaths in Europe.
  • The disease’s name and its old treatments (isolation in sanatoriums) are rooted deep in medical and social history.

2. Current TB Trends in the U.S.

• Rising Cases:
  • After decades of decline, TB cases are rising again, with over 10,000 cases in 2023 and 2024—a 15% jump from the previous year and the highest in more than a decade. (05:33)
  • "So since there are headlines out there about this, I thought maybe we talk about it a little bit..." (04:55)
• Modern Echoes of the Past:
  • TB's stigma and isolation measures have changed little since historical times, mirroring some COVID-19 pandemic protocols (e.g., isolation rooms, negative pressure, visitor restrictions).
  • "It kind of reminds me of COVID. ...But tuberculosis, we still do [isolation]." (09:35)
• Not Easily Treated:
  • TB is caused by a resilient bacterium (Mycobacterium tuberculosis), requiring lengthy treatment (months) rather than a typical 5-7 day antibiotic course.

3. Public Health Success & Setbacks

• Layered Solutions, Not a ‘Silver Bullet’:
  • TB’s historic decline wasn’t due solely to antibiotics, but to comprehensive public health measures: better housing, nutrition, screening, contact tracing, and directly observed therapy.
  • "Directly observed therapy ... all of these systems, they worked." (11:24)
• Recent Reversal:
  • Progress is slipping since 2021, largely due to COVID-19 disruptions: fewer screenings, treatment interruptions, and general diagnostic slowdown as focus shifted to the pandemic.

4. Role of Latent TB and Migration

• Latent vs. Active TB:
  • About 13 million people in the U.S. have latent TB; they aren’t ill, but carry the bacteria and may develop/activate the disease later.
  • "You have around 13 million people who have what's called latent TB..." (13:22)
• Disrupted Services During COVID-19:
  • The pandemic led to less screening and incomplete treatments; priorities shifted away from conditions like TB, cancer, and heart disease.
  • "People only cared about COVID during that time. They didn't care about cancer, ... and they certainly didn't care about tuberculosis." (13:49)
• Migration & Border Factors:
  • "Most TB cases... occur in individuals who are born outside of the country who now migrate into the U.S. This isn't about blame – I'm not trying to point fingers at anybody." (14:10)
  • The issue isn’t just border crossing, but the management of latent TB that may become active years later.

5. Public Health Recommendations and Solutions

• Improved Screening & Follow-Up:
  • Stronger, expanded screening at borders and in high-risk settings (prisons, shelters).
  • Ensuring treatment completion is critical for public health: "It's one thing to diagnose it, it's another ... to make sure they have completed that entire course and it has done the trick." (16:05)
• Affordability and Access:
  • Treatment for latent TB must be accessible and affordable. Support systems (weekly check-ins, incentives) may be necessary to ensure completion.
• Public Health Investment:
  • Emphasis on the need to re-invest in essential infrastructure: public health nurses, social workers, community follow-up, and global coordination.
  • "We have to reinvest in our public health infrastructure. ...The reality is this is the health of the nation." (17:45)

Notable Quotes & Memorable Moments

• Humor about History:
  • "Maybe you've seen these headlines, maybe you haven't. They're definitely out there, and they sound dramatic. ...I just found myself sitting there. I'm like, white plague? What the heck is the white plague?" (03:59–04:10)
• Current State:
  • “With over 10,000 cases in 2024, that was the highest levels we’ve seen in more than a decade.” (05:54)
• On Isolation:
  • "Meals left at the door, no visitors, care delivered at a distance. Does this sound familiar? ... It kind of reminds me of COVID." (08:32)
• Latent TB's Danger:
  • “The bacteria are kind of like living inside of you, but they're silent, they're sneaky. ...It's just waiting for your immunity to drop.” (15:00)
• Border and Migrant Health:
  • “If you're screening [people crossing the border] solely for symptoms, the majority probably don't have active TB ... doesn't mean they don't have latent TB.” (15:20)
• Vigilance Over Complacency:
  • “Medicine, success isn’t permanent, it is maintained. ...We have lagged a little bit when it comes to tuberculosis, so we need to get back to it.” (21:40)

Timestamps for Important Segments

• 03:54 – Introduction to "white plague" and mainstream headlines
• 06:05 – Explanation of TB's historic impact and medical discovery
• 09:14 – Modern hospital protocols for TB; COVID-19 parallels
• 11:18 – Layered public health efforts and their historical success
• 12:55 – Impact of the COVID pandemic on TB screening and treatment
• 13:22 – Discussion on latent TB in the U.S. and global migration
• 15:00 – Latency, triggers for activation, and the importance of long-term management
• 16:40 – Screening, treatment adherence, and structural challenges
• 17:53 – Call for renewed public health investment
• 20:35 – Conclusion and reiteration of vigilance against TB

Episode Takeaway

Dr. Saphire reminds listeners that while TB may sound like a relic of history, its resurgence is real and demands renewed public health focus. The solution lies not just in medicine, but in infrastructure, vigilance, and a community-wide commitment to early detection, comprehensive treatment, and global cooperation.

This summary captures the essence, insights, and memorable lines of the episode, offering a thorough understanding for those who have not listened.